The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Shareholders’ Association seeks additional resolutions at special meeting as former banned director Alan Lai pushes for reinstatement as chair.
The King Honey founder and Me Today’s second-largest shareholder’s investment in the NZX-listed company totals about $17m.
Major shareholders representing more than 30% of issued capital appoint two new directors.
Former Supreme Court judge to oversee talks between Fletcher subsidiary Iplex and building companies over costs of repairing thousands of homes.
Civil proceedings filed against listed insurer, which apologises ‘unreservedly’ for the mistakes.
Dairy co-op exec doesn’t see interest in health and wellness fading any time soon.
Managing director of ASX-listed New Zealand Coastal Seafoods takes shot at New Zealand operation's 'lazy' 'cowboys'.
Shareholder feedback pushes chair to quit early, but other institutions don't support wholesale change of directors.
Sale of Australian business, announced last February, extending 'longer than anticipated'.